At Mölnlycke Health Care, we are dedicated to alleviating the burden of diabetic foot ulcers through innovative solutions and our constant support for healthcare professionals. Our commitment to advancing wound care ensures that we continuously explore new ways to empower clinicians and enhance patient outcomes.
Join us on Friday 6th September at our symposium "Optimising Topical Hemoglobin Therapy for Diabetes-Related Foot Ulcers: A Clinical Decision Support Tool". Here experts will unveil a new clinical decision support tool aimed at optimising Granulox® topical hemoglobin spray for diabetes-related foot ulcers. We look forward to your participation! Click here for details.
